Selectis Health (GBCS) Gross Profit (2018 - 2025)

Selectis Health (GBCS) has 8 years of Gross Profit data on file, last reported at $2.7 million in Q4 2025.

• Quarterly Gross Profit rose 5.51% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.7 million (up 6.01% YoY) and the FY2025 annual result came in at $9.7 million, up 6.01% from the prior year.
• Gross Profit advanced to $2.7 million in Q4 2025 per GBCS's latest filing, from $2.3 million in the prior quarter.
• The five-year high for Gross Profit was $4.5 million in Q2 2022, with the low at $1.1 million in Q1 2023.
• Average Gross Profit over 5 years is $2.2 million, with a median of $2.3 million recorded in 2021.
• Year-over-year, Gross Profit surged 228.92% in 2022 and sank 66.32% in 2023.
• Selectis Health's Gross Profit stood at $1.3 million in 2021, then soared by 59.89% to $2.1 million in 2022, then slumped by 31.51% to $1.5 million in 2023, then jumped by 73.28% to $2.5 million in 2024, then grew by 5.51% to $2.7 million in 2025.
• Business Quant data shows GBCS's Gross Profit at $2.7 million in Q4 2025, $2.3 million in Q3 2025, and $2.3 million in Q2 2025.